biliary dyskinesia
biliary dyskinesia
Explore linked clinical trials. Standard reference: MONDO:00056677 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing | Chronic Disease, Chronic Pain, Digestive System Diseases, Disease Attributes, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sphincter of Oddi Dysfunction, bile duct disorder, biliary dyskinesia, biliary tract disorder, chronic pancreatitis, common bile duct disorder, pancreas disorder, pancreatitis | Recruiting | Not applicable | 2026-09-11 | NCT03434392 | |
| Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers | Digestive System Diseases, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder | Recruiting | Phase 1 | 2026-06-15 | NCT07594977 | |
| Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia | Digestive System Diseases, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder | Recruiting | Phase 3 | 2026-05-19 | NCT07595003 | |
| Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) | Anorectal Diseases, Crohn disease, Digestive System Diseases, Sphincter of Oddi Dysfunction, bile duct disorder, biliary dyskinesia, biliary tract disorder, bowel dysfunction, colitis, colonic disorder, common bile duct disorder, digestive system disorder, esophageal disorder, gallbladder disorder, gastroenteritis, indeterminate colitis, inflammatory bowel disease, intestinal disorder, rectal disorder, ulcerative colitis | Recruiting | Not stated | 2026-04-24 | NCT06315179 | |
| Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. | Deglutition Disorders, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, bile duct disorder, biliary dyskinesia, biliary tract disorder, cholelithiasis, colonic disorder, common bile duct disorder, digestive system disorder, dyskinesia of esophagus, esophageal disorder, functional colonic disease, gastroesophageal reflux disease, intestinal disorder, irritable bowel syndrome, postcholecystectomy syndrome | Recruiting | Phase 1 | 2026-02-19 | NCT07421011 | |
| Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia | Digestive System Diseases, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder | Recruiting | Phase 2 | 2025-07-11 | NCT06842966 | |
| Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis | Digestive System Diseases, Jaundice, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Sphincter of Oddi Dysfunction, bile duct disorder, biliary dyskinesia, biliary tract disorder, common bile duct disorder, hyperbilirubinemia, obstructive jaundice | Recruiting | Not applicable | 2024-10-24 | NCT03977779 |